January 24, 2025
TOPLINE: Combining dapagliflozin with calorie restriction achieved a greater type 2 diabetes (T2D) remission rate and significant changes in body fat and metabolic risk factors than […]
January 23, 2025
TOPLINE: Fasting plasma glucose levels outside 80-94 mg/dL, male sex, older age, and abnormal body mass index (BMI) categories all contribute to diabetes development, with additive […]
January 23, 2025
A study of more than two million people with diabetes builds on evidence of broad-ranging benefits and risks of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) […]
January 23, 2025
TOPLINE: Patients with type 2 diabetes (T2D) on metformin face a lower risk for all-cause dementia than those not on metformin, with the protective effect being […]
January 22, 2025
TOPLINE: A 14-day treatment regimen with vonoprazan plus amoxicillin is effective and safe for eradicating Helicobacter pylori (H pylori) infections in patients with type 2 diabetes […]
January 22, 2025
Physical inactivity increases the risk for diabetes, other chronic diseases, and premature death and should be screened for and managed, new research suggested. “There is nearly […]
January 21, 2025
TOPLINE: Time-restricted eating (TRE) doesn’t significantly reduce visceral adipose tissue (VAT) but leads to significant reductions in body weight compared with usual care in adults with […]
January 21, 2025
Patients with low-risk differentiated thyroid cancer show similar outcomes after 5 years regardless of whether they received radioactive iodine following total thyroidectomy, results from a randomized […]
January 17, 2025
(Reuters) -Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do not inform patients of the risks […]